logo
Search orAI Icon𝛼SK
ENTITY

Genfit (GNFT US)

1
Analysis
Health Care • France
Genfit operates as a biopharmaceutical company. The Company focuses on the discovery and development of drug candidates and innovative diagnostic solutions. Genfit targets metabolic diseases and liver pathologies associated with them.
more
Exchange Announcement • 17 Jan 2024 19:00

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 (PDF)

Exchange Announcement • 12 Jan 2024 05:10

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 (PDF)

Exchange Announcement • 08 Dec 2023 21:00

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 (PDF)

Exchange Announcement • 07 Dec 2023 19:37

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 (PDF)

Exchange Announcement • 07 Dec 2023 00:30

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 (PDF)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.60.3

x